2025年5月，南京中医药大学朱栋教授团队在国际知名期刊Biosensors & Bioelectronics发表了名为“GO-aptamer hydrogel microneedle sensors for the on-site ...

York biotech company, the Aptamer Group has announced part two of a testing programme with Unilever. The deal sees Aptamer ...

York biotech company, the Aptamer Group has announced part two of a testing programme with Unilever. The deal sees Aptamer develop a novel panel of Optimer binders targeting an extra biological ...

在国际权威期刊ACS Nano上，发表题为《适配体功能化的双药递送系统协同治疗肥胖》（Aptamer-Functionalized Binary-Drug Delivery System for Synergetic Obesity Therapy）的高水平文章。该研究针对大蒜素在实际应用中存在溶解度差，气味刺激，靶向性弱，生物利用率低等问题 ...

Biotechnology firm Aptamer announced on Friday that it has secured a second Optimer discovery and development programme with ...

York-based biotech firm Aptamer Group has announced that it has signed on a second discovery and development programme with ...

Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, presented new data on its Optimer therapeutic delivery vehicle for ...

Now, researchers from Japan have discovered that an anti-nucleolin DNA aptamer, iSN04, can determine a cell’s lineage during differentiation. By demonstrating the generation of cardiomyocytes ...

Aptamer's binders are essentially synthetic antibodies, attaching to targets in the body. The binders developed by Aptamer in its first contract with Unilever have passed the lab-testing phase, with ...

"And the existing aptamer test for cocaine isn't sensitive and specific enough to detect clinically relevant amounts of the drug in biological samples, like blood. The sensors we developed can ...